Lexaria Bioscience Corp LEXX

Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs

[Jonathon Brown]

The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector. read article.

[PressRelease]

(TheNewswire)Weight Loss and Blood Sugar Reduction are Major Efficacy ObjectivesKelowna, British Columbia – June 18, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces it has now hired a...read article.

[PressRelease]

(TheNewswire)Second study arm dosing is now complete.Kelowna, British Columbia – June 5, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the “Study”)...read article.

[lscfa]

https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_04292024_LEXX_Vandermosten.pdf

[shawk]

449582_5fcc34c0fab94b83b1de08806f21dace.pdf (letstoke.biz)

[whytestocks]

Just In: $LEXX Lexaria Bioscience Corp. (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study; Maintains Study Pace and Rollout for 2024Lexaria, a global innovator in drug

[PressRelease]

(TheNewswire)First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKelowna, British Columbia – May 23, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms...read article.

[PressRelease]

(TheNewswire)Kelowna, British Columbia – TheNewswire - May 21, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces two important new patent awards.The Company has received a new granted patent in Lexaria’s...read article.

[Yowza123]

https://ir.lexariabioscience.com/news-events/press-releases/detail/250/dosing-begins-in-lexarias-comprehensive-glp-1-animal-study

[shawk]

PowerPoint Presentation (d1io3yog0oux5.cloudfront.net)

[Yowza123]

https://ir.lexariabioscience.com/news-events/press-releases/detail/249/lexaria-begins-dosing-of-its-second-glp-1-human-pilot-study

[whytestocks]

NEWS: $LEXX InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 DrugsLexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global

[whytestocks]

Breaking News: $LEXX Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and IssuanceKELOWNA, BC / ACCESSWIRE / April 30, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW

[ranman]

I'm interested to see if tomorrow's presentation motivates people to buy a few Lexaria Lexaria presents tomorrow at 10:30 am https://ldinv14.sequireevents.com/ Gatekeeper presents tomorrw at

[PressRelease]

(TheNewswire)Lexaria receives new patents in the fields of epilepsy and anti-viral agentsKelowna, British Columbia – April 2, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces three recent...read article.

[PressRelease]

Kelowna, British Columbia--(Newsfile Corp. - March 21, 2024) - Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it will be presenting at the 14th Annual LD Micro Invitational at the Sofitel New York...read article.